77 related articles for article (PubMed ID: 18624812)
1. CXCR4, inhibitors and mechanisms of action.
Liang X
Chem Biol Drug Des; 2008 Aug; 72(2):97-110. PubMed ID: 18624812
[TBL] [Abstract][Full Text] [Related]
2. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
3. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A
J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking.
Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J
J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095
[TBL] [Abstract][Full Text] [Related]
5. Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development.
Singh S; Malik BK; Sharma DK
Chem Biol Drug Des; 2007 Mar; 69(3):191-203. PubMed ID: 17441905
[TBL] [Abstract][Full Text] [Related]
6. The candidate sulfonated microbicide, PRO 2000, has potential multiple mechanisms of action against HIV-1.
Huskens D; Vermeire K; Profy AT; Schols D
Antiviral Res; 2009 Oct; 84(1):38-47. PubMed ID: 19664662
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 envelope protein gp140 binding studies to human brain microvascular endothelial cells.
Mendu DR; Katinger H; Sodroski J; Kim KS
Biochem Biophys Res Commun; 2007 Nov; 363(3):466-71. PubMed ID: 17888880
[TBL] [Abstract][Full Text] [Related]
8. Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.
Thoma G; Streiff MB; Kovarik J; Glickman F; Wagner T; Beerli C; Zerwes HG
J Med Chem; 2008 Dec; 51(24):7915-20. PubMed ID: 19053768
[TBL] [Abstract][Full Text] [Related]
9. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
11. Insight into the binding mode for cyclopentapeptide antagonists of the CXCR4 receptor.
Våbenø J; Nikiforovich GV; Marshall GR
Chem Biol Drug Des; 2006 May; 67(5):346-54. PubMed ID: 16784459
[TBL] [Abstract][Full Text] [Related]
12. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
Ansari AW; Heiken H; Moenkemeyer M; Schmidt RE
Immunol Lett; 2007 May; 110(1):1-5. PubMed ID: 17434211
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipids: modulators of HIV-1 infection and pathogenesis.
Rawat SS; Johnson BT; Puri A
Biosci Rep; 2005; 25(5-6):329-43. PubMed ID: 16307380
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
Santos-Costa Q; Mansinho K; Moniz-Pereira J; Azevedo-Pereira JM
Virus Res; 2009 Jun; 142(1-2):41-50. PubMed ID: 19200444
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles.
DeMarco SJ; Henze H; Lederer A; Moehle K; Mukherjee R; Romagnoli B; Robinson JA; Brianza F; Gombert FO; Lociuro S; Ludin C; Vrijbloed JW; Zumbrunn J; Obrecht JP; Obrecht D; Brondani V; Hamy F; Klimkait T
Bioorg Med Chem; 2006 Dec; 14(24):8396-404. PubMed ID: 17010618
[TBL] [Abstract][Full Text] [Related]
16. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the env gene of two CCR5/CXCR4-independent human immunodeficiency 2 primary isolates.
Santos-Costa Q; Parreira R; Moniz-Pereira J; Azevedo-Pereira JM
J Med Virol; 2009 Nov; 81(11):1869-81. PubMed ID: 19774680
[TBL] [Abstract][Full Text] [Related]
18. A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists.
Våbenø J; Nikiforovich GV; Marshall GR
Biopolymers; 2006; 84(5):459-71. PubMed ID: 16552740
[TBL] [Abstract][Full Text] [Related]
19. NMR structures of anti-HIV D-peptides derived from the N-terminus of viral chemokine vMIP-II.
Mori M; Liu D; Kumar S; Huang Z
Biochem Biophys Res Commun; 2005 Sep; 335(3):651-8. PubMed ID: 16115468
[TBL] [Abstract][Full Text] [Related]
20. Modest human immunodeficiency virus coreceptor function of CXCR3 is strongly enhanced by mimicking the CXCR4 ligand binding pocket in the CXCR3 receptor.
Hatse S; Huskens D; Princen K; Vermeire K; Bridger GJ; De Clercq E; Rosenkilde MM; Schwartz TW; Schols D
J Virol; 2007 Apr; 81(7):3632-9. PubMed ID: 17251291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
